000 | 01812 a2200553 4500 | ||
---|---|---|---|
005 | 20250515092000.0 | ||
264 | 0 | _c20080116 | |
008 | 200801s 0 0 eng d | ||
022 | _a1398-9995 | ||
024 | 7 |
_a10.1111/j.1398-9995.2007.01557.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLuijk, B | |
245 | 0 | 0 |
_aEffect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. _h[electronic resource] |
260 |
_bAllergy _cJan 2008 |
||
300 |
_a75-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdenosine A2 Receptor Antagonists |
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAllergens |
650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAsthma _xdiagnosis |
650 | 0 | 4 | _aBronchial Provocation Tests |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFluticasone |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aRespiratory Function Tests |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _avan den Berge, M | |
700 | 1 | _aKerstjens, H A M | |
700 | 1 | _aPostma, D S | |
700 | 1 | _aCass, L | |
700 | 1 | _aSabin, A | |
700 | 1 | _aLammers, J-W J | |
773 | 0 |
_tAllergy _gvol. 63 _gno. 1 _gp. 75-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1398-9995.2007.01557.x _zAvailable from publisher's website |
999 |
_c17465130 _d17465130 |